These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 32619318)

  • 1. COVID-19 drug repurposing: Summary statistics on current clinical trials and promising untested candidates.
    Ulm JW; Nelson SF
    Transbound Emerg Dis; 2021 Mar; 68(2):313-317. PubMed ID: 32619318
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Repositioning of Drugs to Counter COVID-19 Pandemic - An Insight.
    Akilesh SM; J R; Palanisamy D; Wadhwani A
    Curr Pharm Biotechnol; 2021; 22(2):192-199. PubMed ID: 32867651
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drugs repurposing for SARS-CoV-2: new insight of COVID-19 druggability.
    Debnath SK; Debnath M; Srivastava R; Omri A
    Expert Rev Anti Infect Ther; 2022 Sep; 20(9):1187-1204. PubMed ID: 35615888
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Repurposing anticancer drugs for the management of COVID-19.
    El Bairi K; Trapani D; Petrillo A; Le Page C; Zbakh H; Daniele B; Belbaraka R; Curigliano G; Afqir S
    Eur J Cancer; 2020 Dec; 141():40-61. PubMed ID: 33125946
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elucidating the Drug Repurposing Spectra of COVID-19 with its Analogues SARS and MERS.
    Mishra J; Prasun C; Sahoo PK; Nair MS
    Mini Rev Med Chem; 2021; 21(20):3191-3202. PubMed ID: 33632095
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug Repurposing: An Alternative Strategy to Treat COVID-19.
    Han P; Zheng H; Wen P; Pan L; Geng D; Sun D
    Curr Pharm Biotechnol; 2022; 23(6):818-827. PubMed ID: 34250872
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Niclosamide-A promising treatment for COVID-19.
    Singh S; Weiss A; Goodman J; Fisk M; Kulkarni S; Lu I; Gray J; Smith R; Sommer M; Cheriyan J
    Br J Pharmacol; 2022 Jul; 179(13):3250-3267. PubMed ID: 35348204
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential Repurposing of Drugs with Anti-SARS-CoV-2 Activity in Preclinical Trials: A Systematic Review.
    Rocha YM; de Moura GA; de Oliveira JR; de Figueiredo Nicolete LD; Nicolete R
    Curr Med Chem; 2021; 28(22):4577-4585. PubMed ID: 33019921
    [TBL] [Abstract][Full Text] [Related]  

  • 9. COVID-19: Underpinning Research for Detection, Therapeutics, and Vaccines Development.
    Aljabali AAA; Bakshi HA; Satija S; Metha M; Prasher P; Ennab RM; Chellappan DK; Gupta G; Negi P; Goyal R; Sharma A; Mishra V; Dureja H; Dua K; Tambuwala MM
    Pharm Nanotechnol; 2020; 8(4):323-353. PubMed ID: 32811406
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Repurposing therapeutic agents against SARS-CoV-2 infection: most promising and neoteric progress.
    Hossain MJ; Rahman SMA
    Expert Rev Anti Infect Ther; 2021 Aug; 19(8):1009-1027. PubMed ID: 33355520
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug Discovery of Small Molecules for the Treatment of COVID-19: A Review on Clinical Studies.
    Goel B; Bhardwaj N; Tripathi N; Jain SK
    Mini Rev Med Chem; 2021; 21(12):1431-1456. PubMed ID: 33371848
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Investigational antiviral drugs for the treatment of COVID-19 patients.
    Beheshtirouy S; Khani E; Khiali S; Entezari-Maleki T
    Arch Virol; 2022 Mar; 167(3):751-805. PubMed ID: 35138438
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The growing complexity of COVID-19 drug and vaccine candidates: challenges and critical transitions.
    Shariare MH; Parvez MAK; Karikas GA; Kazi M
    J Infect Public Health; 2021 Feb; 14(2):214-220. PubMed ID: 33493917
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comprehensive Consensus Analysis of SARS-CoV-2 Drug Repurposing Campaigns.
    Mslati H; Gentile F; Perez C; Cherkasov A
    J Chem Inf Model; 2021 Aug; 61(8):3771-3788. PubMed ID: 34313439
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Repurposing Drugs for COVID-19: An Approach for Treatment in the Pandemic.
    Khadka S; Yuchi A; Shrestha DB; Budhathoki P; Al-Subari SMM; Ziad Alhouzani TM; Anwar Butt I
    Altern Ther Health Med; 2020 Aug; 26(S2):100-107. PubMed ID: 32827400
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Robust antiviral activity of commonly prescribed antidepressants against emerging coronaviruses: in vitro and in silico drug repurposing studies.
    Kutkat O; Moatasim Y; Al-Karmalawy AA; Abulkhair HS; Gomaa MR; El-Taweel AN; Abo Shama NM; GabAllah M; Mahmoud DB; Kayali G; Ali MA; Kandeil A; Mostafa A
    Sci Rep; 2022 Jul; 12(1):12920. PubMed ID: 35902647
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Repurposing drugs as COVID-19 therapies: A toxicity evaluation.
    Ngan DK; Xu T; Xia M; Zheng W; Huang R
    Drug Discov Today; 2022 Jul; 27(7):1983-1993. PubMed ID: 35395401
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Repurposing pharmaceutical excipients as an antiviral agent against SARS-CoV-2.
    Malani M; Salunke P; Kulkarni S; Jain GK; Sheikh A; Kesharwani P; Nirmal J
    J Biomater Sci Polym Ed; 2022 Jan; 33(1):110-136. PubMed ID: 34464232
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Small-molecule Antiviral Agents in Ongoing Clinical Trials for COVID-19.
    Apaydın ÇB; Çınar G; Cihan-Üstündağ G
    Curr Drug Targets; 2021; 22(17):1986-2005. PubMed ID: 33588727
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Utilizing clinical pharmacology in the drug repurposing arena: a look into COVID-19.
    Ruggiero R; Balzano N; Di Napoli R; Sullo MG; Rossi F; Capuano A; Rafaniello C
    Expert Rev Clin Pharmacol; 2022 Oct; 15(10):1225-1231. PubMed ID: 36196903
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.